(VIANEWS) – Yesterday, the AICapitalize artificial intelligence algorithm suggested a few financial assets that would make investors a profit today.
Via News is daily fact-checking an AI algorithm that aims to predict financial assets’ next session’s price and next week’s trend.
AICapitalize provides AI-based statistical tools to help investors make decisions.
If you had invested in last session’s AICapitalize AI prediction, you would have a ROI of 0.47%.
| Financial Asset | Accuracy | Prediction | ROI |
|---|---|---|---|
| Exact Sciences (EXAS) | 88.71% | $67.66 | 3.26% ✅ |
| Allstate (ALL) | 88.97% | $173.64 | 1.87% ✅ |
| Regions Financial Corporation (RF) | 88.8% | $21.01 | 1.74% ✅ |
| General Motors (GM) | 88.95% | $45.96 | 1.7% ✅ |
| ING Group (ING) | 94.15% | $16.5 | 1.41% ✅ |
| Bank Of Montreal (BMO) | 92.72% | $98.43 | 1.35% ✅ |
| MGM Resorts (MGM) | 93.24% | $47.55 | 1.31% ✅ |
| Canadian Imperial Bank of Commerce (CM) | 89.54% | $50.34 | 1.3% ✅ |
| Walt Disney (DIS) | 88.42% | $124.33 | 1.14% ✅ |
| Kellogg Company (K) | 88.96% | $58.04 | 1.13% ✅ |
| AbbVie (ABBV) | 89.19% | $181.54 | 0.97% ✅ |
| HSBC (HSBC) | 89.49% | $39.46 | 0.95% ✅ |
| Laboratory Corporation of America Holdings (LH) | 88.2% | $220.62 | 0.87% ✅ |
| Pepsico (PEP) | 88.08% | $178.94 | 0.83% ✅ |
| Raymond James Financial (RJF) | 89.15% | $130.83 | 0.8% ✅ |
| ConAgra Foods (CAG) | 88.34% | $30.3 | 0.51% ✅ |
| General Mills (GIS) | 88% | $71.77 | 0.45% ✅ |
| CVS Health (CVS) | 92.94% | $81.67 | 0.42% ✅ |
| E.I. du Pont de Nemours and Company (DD) | 87.93% | $78.51 | 0.22% ✅ |
| NextEra Energy (NEE) | 87.84% | $65.35 | 0.19% ✅ |
| DraftKings (DKNG) | 88.19% | $47.63 | 0.13% ✅ |
| Banco Santander (SAN) | 99.45% | $4.92 | 0% |
| Aon plc (AON) | 93.3% | $340.23 | -0.02% |
| Eli Lilly and Company (LLY) | 87.92% | $800.71 | -0.03% |
| Toyota (TM) | 88.99% | $258.44 | -0.19% |
| Royal Caribbean Cruises (RCL) | 89.23% | $140.05 | -0.51% |
| CrowdStrike Holdings (CRWD) | 89.14% | $329.01 | -0.52% |
| Amgen (AMGN) | 88.1% | $296.91 | -0.69% |
| Kinder Morgan (KMI) | 94.74% | $18.08 | -1.05% |
| Booking Holdings (BKNG) | 88.05% | $3790.14 | -1.24% |
| Moderna (MRNA) | 92.85% | $115.3 | -3.64% |
1. Exact Sciences (EXAS)
Exact Sciences has been having an accuracy rate of 88.71% over the last 10 sessions. Previous close price was $66.88 the AI prediction was $67.66 and today’s closing price was $69.06. The intraday ROI for Exact Sciences (EXAS) was 3.26%.
Shares of Exact Sciences rose by a staggering 22.4% in from $56.42 to $69.06 at 22:29 EST on Thursday, after five sequential sessions in a row of gains. NASDAQ is falling 0.12% to $16,379.46, following the last session’s downward trend.
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally.
Earnings Per Share
As for profitability, Exact Sciences has a trailing twelve months EPS of $-1.13.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.6%.
More news about Exact Sciences.
2. Allstate (ALL)
Allstate has been having an accuracy rate of 88.97% over the last 10 sessions. Previous close price was $169.84 the AI prediction was $173.64 and today’s closing price was $173.01. The intraday ROI for Allstate (ALL) was 1.87%.
Shares of Allstate jumped 7.81% in from $160.48 to $173.01 at 22:29 EST on Thursday, following the last session’s upward trend. NYSE is jumping 0.31% to $18,312.67, after two consecutive sessions in a row of gains.
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada.
Earnings Per Share
As for profitability, Allstate has a trailing twelve months EPS of $-1.21.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.22%.
Volume
Today’s last reported volume for Allstate is 1174670 which is 33.09% below its average volume of 1755840.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 1, 2024, the estimated forward annual dividend rate is 3.68 and the estimated forward annual dividend yield is 2.35%.
Yearly Top and Bottom Value
Allstate’s stock is valued at $173.01 at 22:29 EST, higher than its 52-week high of $168.05.
Previous days news about Allstate
- Are you looking for a top momentum pick? why allstate (all) is a great choice. According to Zacks on Thursday, 28 March, "Below, we take a look at Allstate (ALL Quick QuoteALL – Free Report) , a company that currently holds a Momentum Style Score of A. We also talk about price change and earnings estimate revisions, two of the main aspects of the Momentum Style Score.", "Shares of Allstate have increased 17.13% over the past quarter, and have gained 54.82% in the last year. "
- Allstate (all) upgraded to buy: what does it mean for the stock?. According to Zacks on Thursday, 28 March, "The upgrade of Allstate to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.", "Therefore, the Zacks rating upgrade for Allstate basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price."
More news about Allstate.
3. Regions Financial Corporation (RF)
Regions Financial Corporation has been having an accuracy rate of 88.8% over the last 10 sessions. Previous close price was $20.68 the AI prediction was $21.01 and today’s closing price was $21.04. The intraday ROI for Regions Financial Corporation (RF) was 1.74%.
Shares of Regions Financial Corporation rose by a staggering 13.42% in from $18.55 to $21.04 at 22:29 EST on Thursday, after four consecutive sessions in a row of gains. NYSE is jumping 0.31% to $18,312.67, after two consecutive sessions in a row of gains.
Regions Financial Corporation, a financial holding company, provides banking and bank-related services to individual and corporate customers.
Earnings Per Share
As for profitability, Regions Financial Corporation has a trailing twelve months EPS of $2.11.
PE Ratio
Regions Financial Corporation has a trailing twelve months price to earnings ratio of 9.97. Meaning, the purchaser of the share is investing $9.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.4%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.6%, now sitting on 7.02B for the twelve trailing months.
Volume
Today’s last reported volume for Regions Financial Corporation is 7631940 which is 15.56% below its average volume of 9038520.
More news about Regions Financial Corporation.
4. General Motors (GM)
General Motors has been having an accuracy rate of 88.95% over the last 10 sessions. Previous close price was $44.59 the AI prediction was $45.96 and today’s closing price was $45.35. The intraday ROI for General Motors (GM) was 1.7%.
Shares of General Motors rose by a staggering 11.56% in from $40.65 to $45.35 at 22:29 EST on Thursday, after four sequential sessions in a row of gains. NYSE is jumping 0.31% to $18,312.67, after two consecutive sessions in a row of gains.
General Motors Company designs, builds, and sells trucks, crossovers, cars, and automobile parts; and provide software-enabled services and subscriptions worldwide.
Earnings Per Share
As for profitability, General Motors has a trailing twelve months EPS of $7.32.
PE Ratio
General Motors has a trailing twelve months price to earnings ratio of 6.2. Meaning, the purchaser of the share is investing $6.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14%.
Previous days news about General Motors
- Are auto-tires-trucks stocks lagging General Motors (gm) this year?. According to Zacks on Wednesday, 27 March, "This shows that General Motors Company is outperforming its peers so far this year.", "Is General Motors Company (GM Quick QuoteGM – Free Report) one of those stocks right now? "
More news about General Motors.
5. ING Group (ING)
ING Group has been having an accuracy rate of 94.15% over the last 10 sessions. Previous close price was $16.26 the AI prediction was $16.5 and today’s closing price was $16.49. The intraday ROI for ING Group (ING) was 1.41%.
Shares of ING Group jumped by a staggering 20.19% in from $13.72 to $16.49 at 22:29 EST on Thursday, after five successive sessions in a row of gains. NYSE is rising 0.31% to $18,312.67, after two successive sessions in a row of gains.
ING Groep N.V. provides various banking products and services in the Netherlands, Belgium, Germany, rest of Europe, and internationally.
Earnings Per Share
As for profitability, ING Group has a trailing twelve months EPS of $2.21.
PE Ratio
ING Group has a trailing twelve months price to earnings ratio of 7.46. Meaning, the purchaser of the share is investing $7.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.78%.
More news about ING Group.
6. Bank Of Montreal (BMO)
Bank Of Montreal has been having an accuracy rate of 92.72% over the last 10 sessions. Previous close price was $96.38 the AI prediction was $98.43 and today’s closing price was $97.68. The intraday ROI for Bank Of Montreal (BMO) was 1.35%.
Shares of Bank Of Montreal jumped 9.19% in from $89.46 to $97.68 at 22:29 EST on Thursday, after four consecutive sessions in a row of gains. NYSE is rising 0.31% to $18,312.67, after two consecutive sessions in a row of gains.
Bank of Montreal provides diversified financial services primarily in North America.
Earnings Per Share
As for profitability, Bank Of Montreal has a trailing twelve months EPS of $5.35.
PE Ratio
Bank Of Montreal has a trailing twelve months price to earnings ratio of 18.26. Meaning, the purchaser of the share is investing $18.26 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.28%.
More news about Bank Of Montreal.
7. MGM Resorts (MGM)
MGM Resorts has been having an accuracy rate of 93.24% over the last 10 sessions. Previous close price was $46.6 the AI prediction was $47.55 and today’s closing price was $47.21. The intraday ROI for MGM Resorts (MGM) was 1.31%.
Shares of MGM Resorts rose by a staggering 11.82% in from $42.22 to $47.21 at 22:29 EST on Thursday, after four consecutive sessions in a row of gains. NYSE is rising 0.31% to $18,312.67, after two sequential sessions in a row of gains.
MGM Resorts International, through its subsidiaries, owns and operates casino, hotel, and entertainment resorts in the United States and internationally.
Earnings Per Share
As for profitability, MGM Resorts has a trailing twelve months EPS of $3.19.
PE Ratio
MGM Resorts has a trailing twelve months price to earnings ratio of 14.8. Meaning, the purchaser of the share is investing $14.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.01%.
Volatility
MGM Resorts’s last week, last month’s, and last quarter’s current intraday variation average was 1.59%, 0.46%, and 1.20%.
MGM Resorts’s highest amplitude of average volatility was 1.59% (last week), 0.93% (last month), and 1.20% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 29.5% and a drop 10.2% for the next.
Moving Average
MGM Resorts’s worth is above its 50-day moving average of $43.83 and way above its 200-day moving average of $42.14.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MGM Resorts’s EBITDA is 2.62.
More news about MGM Resorts.
8. Canadian Imperial Bank of Commerce (CM)
Canadian Imperial Bank of Commerce has been having an accuracy rate of 89.54% over the last 10 sessions. Previous close price was $50.07 the AI prediction was $50.34 and today’s closing price was $50.72. The intraday ROI for Canadian Imperial Bank of Commerce (CM) was 1.3%.
Shares of Canadian Imperial Bank of Commerce jumped 9.78% in from $46.2 to $50.72 at 22:29 EST on Thursday, following the last session’s upward trend. NYSE is jumping 0.31% to $18,312.67, after two consecutive sessions in a row of gains.
Canadian Imperial Bank of Commerce, a diversified financial institution, provides various financial products and services to personal, business, public sector, and institutional clients in Canada, the United States, and internationally.
Earnings Per Share
As for profitability, Canadian Imperial Bank of Commerce has a trailing twelve months EPS of $4.81.
PE Ratio
Canadian Imperial Bank of Commerce has a trailing twelve months price to earnings ratio of 10.54. Meaning, the purchaser of the share is investing $10.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.14%.
Volatility
Canadian Imperial Bank of Commerce’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.06%, a positive 0.33%, and a positive 0.80%.
Canadian Imperial Bank of Commerce’s highest amplitude of average volatility was 0.27% (last week), 0.61% (last month), and 0.80% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 6.2% and positive 10.9% for the next.
Moving Average
Canadian Imperial Bank of Commerce’s value is higher than its 50-day moving average of $46.52 and way above its 200-day moving average of $42.24.
More news about Canadian Imperial Bank of Commerce.
9. Walt Disney (DIS)
Walt Disney has been having an accuracy rate of 88.42% over the last 10 sessions. Previous close price was $120.98 the AI prediction was $124.33 and today’s closing price was $122.36. The intraday ROI for Walt Disney (DIS) was 1.14%.
Shares of Walt Disney rose by a staggering 10.33% in from $110.9 to $122.36 at 22:29 EST on Thursday, after four consecutive sessions in a row of gains. NYSE is rising 0.31% to $18,312.67, after two successive sessions in a row of gains.
The Walt Disney Company operates as an entertainment company worldwide.
Earnings Per Share
As for profitability, Walt Disney has a trailing twelve months EPS of $1.63.
PE Ratio
Walt Disney has a trailing twelve months price to earnings ratio of 75.07. Meaning, the purchaser of the share is investing $75.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.9%.
More news about Walt Disney.
10. Kellogg Company (K)
Kellogg Company has been having an accuracy rate of 88.96% over the last 10 sessions. Previous close price was $56.65 the AI prediction was $58.04 and today’s closing price was $57.29. The intraday ROI for Kellogg Company (K) was 1.13%.
Shares of Kellogg Company jumped 2.32% in from $55.99 to $57.29 at 22:29 EST on Thursday, after five successive sessions in a row of gains. NYSE is jumping 0.31% to $18,312.67, after two sequential sessions in a row of gains.
Kellanova, together with its subsidiaries, manufactures and markets snacks and convenience foods in North America, Europe, Latin America, the Asia Pacific, the Middle East, Australia, and Africa.
Earnings Per Share
As for profitability, Kellogg Company has a trailing twelve months EPS of $2.25.
PE Ratio
Kellogg Company has a trailing twelve months price to earnings ratio of 25.46. Meaning, the purchaser of the share is investing $25.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.35%.
More news about Kellogg Company.
11. AbbVie (ABBV)
AbbVie has been having an accuracy rate of 89.19% over the last 10 sessions. Previous close price was $180.35 the AI prediction was $181.54 and today’s closing price was $182.1. The intraday ROI for AbbVie (ABBV) was 0.97%.
Shares of AbbVie rose 2.29% in from $178.02 to $182.10 at 22:29 EST on Thursday, after five successive sessions in a row of gains. NYSE is jumping 0.31% to $18,312.67, after two consecutive sessions in a row of gains.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide.
Earnings Per Share
As for profitability, AbbVie has a trailing twelve months EPS of $2.72.
PE Ratio
AbbVie has a trailing twelve months price to earnings ratio of 66.95. Meaning, the purchaser of the share is investing $66.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.2%.
Sales Growth
AbbVie’s sales growth is negative 2.1% for the present quarter and negative 2.5% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AbbVie’s stock is considered to be oversold (<=20).
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 12, 2024, the estimated forward annual dividend rate is 6.2 and the estimated forward annual dividend yield is 3.47%.
More news about AbbVie.
12. HSBC (HSBC)
HSBC has been having an accuracy rate of 89.49% over the last 10 sessions. Previous close price was $38.99 the AI prediction was $39.46 and today’s closing price was $39.36. The intraday ROI for HSBC (HSBC) was 0.95%.
Shares of HSBC rose 2.5% in from $38.4 to $39.36 at 22:29 EST on Thursday, after two sequential sessions in a row of gains. NYSE is rising 0.31% to $18,312.67, after two sequential sessions in a row of gains.
HSBC Holdings plc provides banking and financial services worldwide.
Earnings Per Share
As for profitability, HSBC has a trailing twelve months EPS of $5.7.
PE Ratio
HSBC has a trailing twelve months price to earnings ratio of 6.91. Meaning, the purchaser of the share is investing $6.91 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13%.
Yearly Top and Bottom Value
HSBC’s stock is valued at $39.36 at 22:29 EST, below its 52-week high of $42.47 and way above its 52-week low of $32.41.
Volatility
HSBC’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.68%, a negative 0.15%, and a positive 1.21%.
HSBC’s highest amplitude of average volatility was 1.14% (last week), 1.12% (last month), and 1.21% (last quarter).
Volume
Today’s last reported volume for HSBC is 1767690 which is 23.09% below its average volume of 2298540.
Moving Average
HSBC’s value is under its 50-day moving average of $39.37 and higher than its 200-day moving average of $38.98.
More news about HSBC.
13. Laboratory Corporation of America Holdings (LH)
Laboratory Corporation of America Holdings has been having an accuracy rate of 88.2% over the last 10 sessions. Previous close price was $216.57 the AI prediction was $220.62 and today’s closing price was $218.46. The intraday ROI for Laboratory Corporation of America Holdings (LH) was 0.87%.
Shares of Laboratory Corporation of America Holdings jumped 1.78% in from $214.64 to $218.46 at 22:29 EST on Thursday, after four sequential sessions in a row of gains. NYSE is jumping 0.31% to $18,312.67, after two successive sessions in a row of gains.
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Earnings Per Share
As for profitability, Laboratory Corporation of America Holdings has a trailing twelve months EPS of $4.33.
PE Ratio
Laboratory Corporation of America Holdings has a trailing twelve months price to earnings ratio of 50.45. Meaning, the purchaser of the share is investing $50.45 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.22%.
Volatility
Laboratory Corporation of America Holdings’s last week, last month’s, and last quarter’s current intraday variation average was 0.52%, 0.01%, and 0.95%.
Laboratory Corporation of America Holdings’s highest amplitude of average volatility was 0.59% (last week), 0.75% (last month), and 0.95% (last quarter).
Volume
Today’s last reported volume for Laboratory Corporation of America Holdings is 557909 which is 24.92% below its average volume of 743178.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Feb 26, 2024, the estimated forward annual dividend rate is 2.88 and the estimated forward annual dividend yield is 1.32%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Laboratory Corporation of America Holdings’s EBITDA is 1.95.
More news about Laboratory Corporation of America Holdings.
14. Pepsico (PEP)
Pepsico has been having an accuracy rate of 88.08% over the last 10 sessions. Previous close price was $173.57 the AI prediction was $178.94 and today’s closing price was $175.01. The intraday ROI for Pepsico (PEP) was 0.83%.
Shares of Pepsico rose 4.75% in from $167.07 to $175.01 at 22:29 EST on Thursday, after four sequential sessions in a row of gains. NASDAQ is dropping 0.12% to $16,379.46, following the last session’s downward trend.
PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of various beverages and convenient foods worldwide.
Earnings Per Share
As for profitability, Pepsico has a trailing twelve months EPS of $6.56.
PE Ratio
Pepsico has a trailing twelve months price to earnings ratio of 26.68. Meaning, the purchaser of the share is investing $26.68 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 50.99%.
Sales Growth
Pepsico’s sales growth is 15.1% for the ongoing quarter and 2.3% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 1.3% and 6.2%, respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Pepsico’s stock is considered to be oversold (<=20).
More news about Pepsico.
15. Raymond James Financial (RJF)
Raymond James Financial has been having an accuracy rate of 89.15% over the last 10 sessions. Previous close price was $127.4 the AI prediction was $130.83 and today’s closing price was $128.42. The intraday ROI for Raymond James Financial (RJF) was 0.8%.
Shares of Raymond James Financial rose 6.79% in from $120.21 to $128.37 at 22:29 EST on Thursday, after two sequential sessions in a row of gains. NYSE is rising 0.31% to $18,312.67, after two sequential sessions in a row of gains.
Raymond James Financial, Inc., a diversified financial services company, provides private client group, capital markets, asset management, banking, and other services to individuals, corporations, and municipalities in the United States, Canada, and Europe.
Earnings Per Share
As for profitability, Raymond James Financial has a trailing twelve months EPS of $7.99.
PE Ratio
Raymond James Financial has a trailing twelve months price to earnings ratio of 16.07. Meaning, the purchaser of the share is investing $16.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.77%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Raymond James Financial’s stock is considered to be oversold (<=20).
Volatility
Raymond James Financial’s last week, last month’s, and last quarter’s current intraday variation average was 0.48%, 0.26%, and 0.86%.
Raymond James Financial’s highest amplitude of average volatility was 1.04% (last week), 0.68% (last month), and 0.86% (last quarter).
More news about Raymond James Financial.
16. ConAgra Foods (CAG)
ConAgra Foods has been having an accuracy rate of 88.34% over the last 10 sessions. Previous close price was $29.49 the AI prediction was $30.3 and today’s closing price was $29.64. The intraday ROI for ConAgra Foods (CAG) was 0.51%.
Shares of ConAgra Foods rose 5.56% in from $28.08 to $29.64 at 22:29 EST on Thursday, after two consecutive sessions in a row of gains. NYSE is jumping 0.31% to $18,312.67, after two sequential sessions in a row of gains.
Conagra Brands, Inc., together with its subsidiaries, operates as a consumer packaged goods food company primarily in the United States.
Earnings Per Share
As for profitability, ConAgra Foods has a trailing twelve months EPS of $2.05.
PE Ratio
ConAgra Foods has a trailing twelve months price to earnings ratio of 14.46. Meaning, the purchaser of the share is investing $14.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.06%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 29, 2024, the estimated forward annual dividend rate is 1.4 and the estimated forward annual dividend yield is 4.98%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ConAgra Foods’s stock is considered to be oversold (<=20).
More news about ConAgra Foods.
17. General Mills (GIS)
General Mills has been having an accuracy rate of 88% over the last 10 sessions. Previous close price was $69.66 the AI prediction was $71.77 and today’s closing price was $69.97. The intraday ROI for General Mills (GIS) was 0.45%.
Shares of General Mills jumped 8.9% in from $64.25 to $69.97 at 22:29 EST on Thursday, after four successive sessions in a row of gains. NYSE is jumping 0.31% to $18,312.67, after two sequential sessions in a row of gains.
General Mills, Inc. manufactures and markets branded consumer foods worldwide.
Earnings Per Share
As for profitability, General Mills has a trailing twelve months EPS of $4.36.
PE Ratio
General Mills has a trailing twelve months price to earnings ratio of 16.05. Meaning, the purchaser of the share is investing $16.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.6%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 7.2% and a drop 1.8% for the next.
Moving Average
General Mills’s value is above its 50-day moving average of $64.32 and above its 200-day moving average of $68.76.
Yearly Top and Bottom Value
General Mills’s stock is valued at $69.97 at 22:29 EST, way under its 52-week high of $90.89 and way above its 52-week low of $60.33.
More news about General Mills.
18. CVS Health (CVS)
CVS Health has been having an accuracy rate of 92.94% over the last 10 sessions. Previous close price was $79.43 the AI prediction was $81.67 and today’s closing price was $79.76. The intraday ROI for CVS Health (CVS) was 0.42%.
Shares of CVS Health jumped 6.23% in from $75.08 to $79.76 at 22:29 EST on Thursday, after five sequential sessions in a row of gains. NYSE is rising 0.31% to $18,312.67, after two consecutive sessions in a row of gains.
CVS Health Corporation provides health solutions in the United States.
Earnings Per Share
As for profitability, CVS Health has a trailing twelve months EPS of $6.47.
PE Ratio
CVS Health has a trailing twelve months price to earnings ratio of 12.33. Meaning, the purchaser of the share is investing $12.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.28%.
Previous days news about CVS Health
- CVS health (cvs) ascends but remains behind market: some facts to note. According to Zacks on Wednesday, 27 March, "The most recent trading session ended with CVS Health (CVS Quick QuoteCVS – Free Report) standing at $79.43, reflecting a +0.14% shift from the previouse trading day’s closing. ", "Investors will be eagerly watching for the performance of CVS Health in its upcoming earnings disclosure. "
More news about CVS Health.
19. E.I. du Pont de Nemours and Company (DD)
E.I. du Pont de Nemours and Company has been having an accuracy rate of 87.93% over the last 10 sessions. Previous close price was $76.5 the AI prediction was $78.51 and today’s closing price was $76.67. The intraday ROI for E.I. du Pont de Nemours and Company (DD) was 0.22%.
Shares of E.I. du Pont de Nemours and Company jumped by a staggering 10.33% in from $69.49 to $76.67 at 22:29 EST on Thursday, after two sequential sessions in a row of gains. NYSE is jumping 0.31% to $18,312.67, after two sequential sessions in a row of gains.
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa.
Earnings Per Share
As for profitability, E.I. du Pont de Nemours and Company has a trailing twelve months EPS of $1.09.
PE Ratio
E.I. du Pont de Nemours and Company has a trailing twelve months price to earnings ratio of 70.34. Meaning, the purchaser of the share is investing $70.34 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.06%.
Moving Average
E.I. du Pont de Nemours and Company’s value is above its 50-day moving average of $70.24 and higher than its 200-day moving average of $72.15.
Volume
Today’s last reported volume for E.I. du Pont de Nemours and Company is 1350950 which is 59.51% below its average volume of 3336690.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, E.I. du Pont de Nemours and Company’s stock is considered to be oversold (<=20).
Volatility
E.I. du Pont de Nemours and Company’s last week, last month’s, and last quarter’s current intraday variation average was 0.33%, 0.63%, and 1.17%.
E.I. du Pont de Nemours and Company’s highest amplitude of average volatility was 0.69% (last week), 0.83% (last month), and 1.17% (last quarter).
More news about E.I. du Pont de Nemours and Company.
20. NextEra Energy (NEE)
NextEra Energy has been having an accuracy rate of 87.84% over the last 10 sessions. Previous close price was $63.79 the AI prediction was $65.35 and today’s closing price was $63.91. The intraday ROI for NextEra Energy (NEE) was 0.19%.
Shares of NextEra Energy jumped by a staggering 16.18% in from $55.01 to $63.91 at 22:29 EST on Thursday, after four consecutive sessions in a row of gains. NYSE is jumping 0.31% to $18,312.67, after two consecutive sessions in a row of gains.
NextEra Energy, Inc., through its subsidiaries, generates, transmits, distributes, and sells electric power to retail and wholesale customers in North America.
Earnings Per Share
As for profitability, NextEra Energy has a trailing twelve months EPS of $3.6.
PE Ratio
NextEra Energy has a trailing twelve months price to earnings ratio of 17.75. Meaning, the purchaser of the share is investing $17.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.58%.
Yearly Top and Bottom Value
NextEra Energy’s stock is valued at $63.91 at 22:29 EST, way under its 52-week high of $79.78 and way higher than its 52-week low of $47.15.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.6%, now sitting on 28.11B for the twelve trailing months.
Volatility
NextEra Energy’s last week, last month’s, and last quarter’s current intraday variation average was 1.09%, 0.88%, and 1.30%.
NextEra Energy’s highest amplitude of average volatility was 2.37% (last week), 1.41% (last month), and 1.30% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 14.3% and positive 10.2% for the next.
More news about NextEra Energy.
21. DraftKings (DKNG)
DraftKings has been having an accuracy rate of 88.19% over the last 10 sessions. Previous close price was $45.35 the AI prediction was $47.63 and today’s closing price was $45.41. The intraday ROI for DraftKings (DKNG) was 0.13%.
Shares of DraftKings rose 7.79% in from $42.13 to $45.41 at 22:29 EST on Thursday, following the last session’s upward trend. NASDAQ is dropping 0.12% to $16,379.46, following the last session’s downward trend.
DraftKings Inc. operates as a digital sports entertainment and gaming company in the United States and internationally.
Earnings Per Share
As for profitability, DraftKings has a trailing twelve months EPS of $-1.73.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -74.17%.
Volume
Today’s last reported volume for DraftKings is 11232100 which is 8.34% below its average volume of 12254100.
More news about DraftKings.
22. Banco Santander (SAN)
Banco Santander has been having an accuracy rate of 99.45% over the last 10 sessions. Previous close price was $4.84 the AI prediction was $4.92 and today’s closing price was $4.84. The intraday ROI for Banco Santander (SAN) was 0%.
Shares of Banco Santander jumped by a staggering 17.23% in from $4.12 to $4.83 at 22:29 EST on Thursday, following the last session’s downward trend. NYSE is rising 0.31% to $18,312.67, after two consecutive sessions in a row of gains.
Banco Santander, S.A. provides various financial services worldwide.
Earnings Per Share
As for profitability, Banco Santander has a trailing twelve months EPS of $0.71.
PE Ratio
Banco Santander has a trailing twelve months price to earnings ratio of 6.8. Meaning, the purchaser of the share is investing $6.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.07%.
More news about Banco Santander.
23. Aon plc (AON)
Aon plc has been having an accuracy rate of 93.3% over the last 10 sessions. Previous close price was $333.79 the AI prediction was $340.23 and today’s closing price was $333.72. The intraday ROI for Aon plc (AON) was -0.02%.
Shares of Aon plc rose 5.45% in from $316.47 to $333.72 at 22:29 EST on Thursday, following the last session’s downward trend. NYSE is jumping 0.31% to $18,312.67, after two consecutive sessions in a row of gains.
Aon plc, a professional services firm, provides a range of risk and human capital solutions worldwide.
Earnings Per Share
As for profitability, Aon plc has a trailing twelve months EPS of $12.52.
PE Ratio
Aon plc has a trailing twelve months price to earnings ratio of 26.65. Meaning, the purchaser of the share is investing $26.65 for every dollar of annual earnings.
More news about Aon plc.
24. Eli Lilly and Company (LLY)
Eli Lilly and Company has been having an accuracy rate of 87.92% over the last 10 sessions. Previous close price was $778.18 the AI prediction was $800.71 and today’s closing price was $777.96. The intraday ROI for Eli Lilly and Company (LLY) was -0.03%.
Shares of Eli Lilly and Company jumped 2.73% in from $757.29 to $777.96 at 22:29 EST on Thursday, following the last session’s downward trend. NYSE is jumping 0.31% to $18,312.67, after two sequential sessions in a row of gains.
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide.
Earnings Per Share
As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $5.84.
PE Ratio
Eli Lilly and Company has a trailing twelve months price to earnings ratio of 133.21. Meaning, the purchaser of the share is investing $133.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.44%.
More news about Eli Lilly and Company.
25. Toyota (TM)
Toyota has been having an accuracy rate of 88.99% over the last 10 sessions. Previous close price was $252.15 the AI prediction was $258.44 and today’s closing price was $251.68. The intraday ROI for Toyota (TM) was -0.19%.
Shares of Toyota jumped 6.08% in from $237.25 to $251.68 at 22:29 EST on Thursday, after four sequential sessions in a row of losses. NYSE is jumping 0.31% to $18,312.67, after two consecutive sessions in a row of gains.
Toyota Motor Corporation designs, manufactures, assembles, and sells passenger vehicles, minivans and commercial vehicles, and related parts and accessories in Japan, North America, Europe, Asia, Central and South America, Oceania, Africa, and the Middle East.
Earnings Per Share
As for profitability, Toyota has a trailing twelve months EPS of $21.96.
PE Ratio
Toyota has a trailing twelve months price to earnings ratio of 11.46. Meaning, the purchaser of the share is investing $11.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.72%.
Volatility
Toyota’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.34%, a positive 0.14%, and a positive 1.28%.
Toyota’s highest amplitude of average volatility was 0.69% (last week), 1.58% (last month), and 1.28% (last quarter).
Volume
Today’s last reported volume for Toyota is 117457 which is 61.8% below its average volume of 307483.
Moving Average
Toyota’s worth is way higher than its 50-day moving average of $212.58 and way above its 200-day moving average of $182.01.
Yearly Top and Bottom Value
Toyota’s stock is valued at $251.68 at 22:29 EST, below its 52-week high of $253.43 and way higher than its 52-week low of $132.35.
More news about Toyota.
26. Royal Caribbean Cruises (RCL)
Royal Caribbean Cruises has been having an accuracy rate of 89.23% over the last 10 sessions. Previous close price was $139.72 the AI prediction was $140.05 and today’s closing price was $139.01. The intraday ROI for Royal Caribbean Cruises (RCL) was -0.51%.
Shares of Royal Caribbean Cruises rose by a staggering 13.39% in from $122.59 to $139.01 at 22:29 EST on Thursday, after two sequential sessions in a row of losses. NYSE is rising 0.31% to $18,312.67, after two successive sessions in a row of gains.
Royal Caribbean Cruises Ltd.
Earnings Per Share
As for profitability, Royal Caribbean Cruises has a trailing twelve months EPS of $6.32.
PE Ratio
Royal Caribbean Cruises has a trailing twelve months price to earnings ratio of 22. Meaning, the purchaser of the share is investing $22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 43.87%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28%, now sitting on 13.9B for the twelve trailing months.
Sales Growth
Royal Caribbean Cruises’s sales growth is 27.2% for the ongoing quarter and 16.1% for the next.
Volume
Today’s last reported volume for Royal Caribbean Cruises is 2267850 which is 15.36% below its average volume of 2679420.
More news about Royal Caribbean Cruises.
27. CrowdStrike Holdings (CRWD)
CrowdStrike Holdings has been having an accuracy rate of 89.14% over the last 10 sessions. Previous close price was $322.25 the AI prediction was $329.01 and today’s closing price was $320.59. The intraday ROI for CrowdStrike Holdings (CRWD) was -0.52%.
Shares of CrowdStrike Holdings rose 0.07% in from $320.37 to $320.59 at 22:29 EST on Thursday, after two sequential sessions in a row of losses. NASDAQ is sliding 0.12% to $16,379.46, following the last session’s downward trend.
CrowdStrike Holdings, Inc. provides cybersecurity solutions in the United States and internationally.
Earnings Per Share
As for profitability, CrowdStrike Holdings has a trailing twelve months EPS of $0.35.
PE Ratio
CrowdStrike Holdings has a trailing twelve months price to earnings ratio of 915.97. Meaning, the purchaser of the share is investing $915.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.74%.
More news about CrowdStrike Holdings.
28. Amgen (AMGN)
Amgen has been having an accuracy rate of 88.1% over the last 10 sessions. Previous close price was $286.3 the AI prediction was $296.91 and today’s closing price was $284.32. The intraday ROI for Amgen (AMGN) was -0.69%.
Shares of Amgen jumped 2.28% in from $277.98 to $284.32 at 22:29 EST on Thursday, following the last session’s downward trend. NASDAQ is falling 0.12% to $16,379.46, following the last session’s downward trend.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
Earnings Per Share
As for profitability, Amgen has a trailing twelve months EPS of $12.48.
PE Ratio
Amgen has a trailing twelve months price to earnings ratio of 22.78. Meaning, the purchaser of the share is investing $22.78 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 135.79%.
More news about Amgen.
29. Kinder Morgan (KMI)
Kinder Morgan has been having an accuracy rate of 94.74% over the last 10 sessions. Previous close price was $18.15 the AI prediction was $18.08 and today’s closing price was $18.34. The intraday ROI for Kinder Morgan (KMI) was -1.05%.
Shares of Kinder Morgan rose 7% in from $17.14 to $18.34 at 22:29 EST on Thursday, after two consecutive sessions in a row of gains. NYSE is rising 0.31% to $18,312.67, after two sequential sessions in a row of gains.
Kinder Morgan, Inc. operates as an energy infrastructure company primarily in North America.
Earnings Per Share
As for profitability, Kinder Morgan has a trailing twelve months EPS of $1.06.
PE Ratio
Kinder Morgan has a trailing twelve months price to earnings ratio of 17.3. Meaning, the purchaser of the share is investing $17.3 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.79%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 11.8%, now sitting on 15.33B for the twelve trailing months.
More news about Kinder Morgan.
30. Booking Holdings (BKNG)
Booking Holdings has been having an accuracy rate of 88.05% over the last 10 sessions. Previous close price was $3673.5 the AI prediction was $3790.14 and today’s closing price was $3627.88. The intraday ROI for Booking Holdings (BKNG) was -1.24%.
Shares of Booking Holdings rose 3.73% in from $3497.43 to $3,627.88 at 22:29 EST on Thursday, following the last session’s downward trend. NASDAQ is sliding 0.12% to $16,379.46, following the last session’s downward trend.
Booking Holdings Inc., together with its subsidiaries, provides online and traditional travel and restaurant reservations and related services in the United States, the Netherlands, and internationally.
Earnings Per Share
As for profitability, Booking Holdings has a trailing twelve months EPS of $117.55.
PE Ratio
Booking Holdings has a trailing twelve months price to earnings ratio of 30.86. Meaning, the purchaser of the share is investing $30.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22573.7%.
Volume
Today’s last reported volume for Booking Holdings is 259714 which is 9.19% below its average volume of 286004.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 20.3% and 9.8%, respectively.
Moving Average
Booking Holdings’s worth is above its 50-day moving average of $3,563.31 and way higher than its 200-day moving average of $3,128.70.
Previous days news about Booking Holdings
- Booking holdings (bkng) advances but underperforms market: key facts. According to Zacks on Wednesday, 27 March, "Looking at its valuation, Booking Holdings is holding a Forward P/E ratio of 20.86. ", "The latest trading session saw Booking Holdings (BKNG Quick QuoteBKNG – Free Report) ending at $3,673.50, denoting a +0.34% adjustment from its last day’s close. "
More news about Booking Holdings.
31. Moderna (MRNA)
Moderna has been having an accuracy rate of 92.85% over the last 10 sessions. Previous close price was $110.59 the AI prediction was $115.3 and today’s closing price was $106.56. The intraday ROI for Moderna (MRNA) was -3.64%.
Shares of Moderna jumped by a staggering 10.09% in from $96.79 to $106.56 at 22:29 EST on Thursday, following the last session’s downward trend. NASDAQ is dropping 0.12% to $16,379.46, following the last session’s downward trend.
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally.
Earnings Per Share
As for profitability, Moderna has a trailing twelve months EPS of $-12.33.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.59%.
Volatility
Moderna’s last week, last month’s, and last quarter’s current intraday variation average was 1.63%, 1.20%, and 2.79%.
Moderna’s highest amplitude of average volatility was 3.48% (last week), 2.40% (last month), and 2.79% (last quarter).
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 1789.5% and positive 8.3% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Moderna’s EBITDA is 4.74.
Revenue Growth
Year-on-year quarterly revenue growth declined by 44.7%, now sitting on 6.85B for the twelve trailing months.
Previous days news about Moderna
- Moderna (mrna) posts upbeat data from next-gen covid jab study. According to Zacks on Wednesday, 27 March, "Last October, Moderna reported positive interim data from a phase I/II study on mRNA-1083 in individuals aged 50 years and older. ", "This has led to a steep decline in sales and profits of Moderna and Pfizer (PFE Quick QuotePFE – Free Report) /BioNTech (BNTX Quick QuoteBNTX – Free Report) , which benefitted from being the first makers of COVID-19 vaccines. "
More news about Moderna.
